PureTech Health plc (PRTC)

PureTech Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-65.7	-50.35	-60.56	5.99	421.14
Depreciation & Amortization	4.93	8.89	7.29	6.65	6.67
Share-Based Compensation	4.42	14.7	13.95	10.72	14.47
Other Operating Activities	-49.57	-152.03	-118.95	-155.18	-540.43
Operating Cash Flow	-105.92	-178.79	-158.27	-131.83	-98.16
Capital Expenditures	0.8	-2.18	-5.54	-5.17	-12.14
Acquisitions	-30.63	-20.44	-15	-10	-29.71
Change in Investments	99.01	-85.02	217.63	379.55	105.71
Other Investing Activities	-0.18	0.42	0.29	0.1	-0.21
Investing Cash Flow	68.99	-107.22	197.38	364.48	63.66
Share Issuance / Repurchase	-18.5	-26.16	-10.4	-11.85	0.5
Debt Issued / Paid	-3.34	-3.63	-1.16	36.88	-0.25
Other Financing Activities	99.98	-0.04	34.28	13.84	49.66
Financing Cash Flow	78.14	-29.83	22.73	38.87	49.91
Exchange Rate Effect	0	0	0	0	-0.1
Net Cash Flow	41.22	-315.84	61.83	271.52	15.31
Free Cash Flow	-105.12	-180.97	-163.82	-137	-110.29
Free Cash Flow Margin	-3156.82%	-1158.71%	-942.12%	-1164.15%	-1124.65%
Free Cash Flow Per Share	-3.77	-6.29	-5.73	-4.79	-3.86

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).